Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NeuroD2 ELISA Kit (AC3600)
Cat.#: ASET-2189
Specifications
Description Human NeuroD2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NeuroD2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.021 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1806 Human Butyrylcholinesterase ELISA Kit (AC3217) Quantitative inquiry ASET-1974 Rat p75 NGF Receptor ELISA Kit (AC3385) Quantitative inquiry ASET-1966 Human DAG1 ELISA Kit (AC3377) Quantitative inquiry ASET-1758 Human DDAH1 ELISA Kit (AC3169) Quantitative inquiry ASET-1336 Human SOX6 ELISA Kit (AC2747) Quantitative inquiry ASET-1910 Human C Peptide ELISA Kit (AC3321) Quantitative inquiry ASET-1098 Human COLEC12 ELISA Kit (AC2509) Quantitative inquiry ASET-1993 Mouse Caspase-12 ELISA Kit (AC3404) Quantitative inquiry ASET-1051 Human LAMP1 ELISA Kit (AC2462) Quantitative inquiry ASET-1580 Human ANGPTL7 ELISA Kit (AC2991) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket